Dexcom Fair Value
DX
The fair market value of DXCM.VI stock is 208.6 EUR. Relative to the market price of 0 EUR Dexcom is undervalued by 216.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Dexcom Valuation
The fair value level of 208.6 EUR can be considered as an effective entry point for long-term investors to start investing in DXCM.VI stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
DXCM.VI stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Dexcom Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
190.78
2
Median P/E over 5 years
127.27
3
Minimum P/E over 5 years
65.68
4
Earning per share (last 12 months)
1.74 USD
Maximum value
1
x
4
=
312.7 EUR
Fair value
2
x
4
=
208.6 EUR
Minimum value
3
x
4
=
107.66 EUR
Dexcom Inc price metrics
6.36
Annual return (geometric mean)
51.03
Risk (standard deviation) of returns
β
0.89
Beta (volatility compared to market)